Clarivate Companies to Watch Report Spotlights Seven Women’s Health Startups Shaping the Future of Care
Report highlights emerging biotech innovators advancing new therapies, equity and investment across…
OMRON Healthcare Announces Second Investment in Tricog Health to Advance AI-Powered Cardiac Care in India
KYOTO, Japan, Nov. 12, 2025 /PRNewswire/ -- OMRON Healthcare Co., Ltd. today…
Apollo Hospitals Achieves Historic Milestone: Completes 5,000 Liver Transplants, Sets a New Benchmark for Indian and South Asian Healthcare
NEW DELHI, Nov. 13, 2025 /PRNewswire/ -- Apollo Hospitals Group today celebrates…
Evidium Announces $22M Funding Close to Scale Computational Medical Knowledge
SAN FRANCISCO, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Evidium, a healthcare AI…
Healthcare Holding Schweiz Acquires a Stake in QUNIQUE
Healthcare Holding Schweiz AG, a leading provider of medical technology services and…
Fangzhou Awarded Golden Bull Award for Leadership in AI-Powered Chronic Disease Management
XIAMEN, China, Nov. 08, 2025 (GLOBE NEWSWIRE) -- Fangzhou Inc. (“Fangzhou” or…
H.H.C. Group Achieves ISO/IEC 27001:2022 Certification, Strengthening Commitment to Data Security and Client Trust
ROCKVILLE, Md., Nov. 04, 2025 (GLOBE NEWSWIRE) -- H.H.C. Group (H.H.C.), a leader…
Oscar Launches New Affordable Health Insurance Choices for San Antonio Individuals, Families, and Businesses
SAN ANTONIO--(BUSINESS WIRE)--Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), a leading healthcare technology…
Belite Bio Announces UKs Medicines and Healthcare Products Regulatory Agency Agrees to Conditional Marketing Authorization Application Based on Interim Analysis Results for the Treatment of Stargardt Disease with Tinlarebant
November 02, 2025 09:00 ET | Source: Belite Bio, Inc MHRA response…
Fangzhous XingJie LLM Completes Key National Filing, Setting Stage for Further AI-Driven Chronic Care Innovations
SHENZHEN, China, Nov. 02, 2025 (GLOBE NEWSWIRE) -- Fangzhou Inc. (“Fangzhou” or…